REALTA LIFE SCIENCES
ReAlta Life Sciences, Inc. is a clinical-stage biotech company dedicated to harnessing the power of the immune system to address life threatening rare diseases. The Company’s EPICC peptides are based on research into the human astrovirus, HAstV-1, which causes a non-inflammatory, self-limiting gastroenteritis unique among viruses by inhibiting components of the innate immune system. ReAlta’s therapeutic peptides leverage these virus-derived mechanisms to rebalance complement and inflammatory... processes in the body. The company’s pipeline is led by RLS-0071, which has been granted Orphan Drug Designation by the U.S. Food and Drug Administration and European Medicines Agency for the treatment of hypoxic ischemic encephalopathy (HIE) in neonates. The company launched in 2018 and is located in Norfolk, Virginia. For more information, please visit www.realtalifesciences.com.
REALTA LIFE SCIENCES
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2018-01-01
Address:
Norfolk, Virginia, United States
Country:
United States
Website Url:
http://www.realtalifesciences.com
Total Employee:
11+
Status:
Active
Contact:
(757) 901-0460
Total Funding:
53.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Global Site Tag Nginx
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Employees Featured
Founder
Investors List
Virginia Catalyst
Virginia Catalyst investment in Grant - ReAlta Life Sciences
Marathon Pharmaceuticals
Marathon Pharmaceuticals investment in Series A - ReAlta Life Sciences
Children’s Research Holdings
Children’s Research Holdings investment in Series A - ReAlta Life Sciences
Marathon Pharmaceuticals
Marathon Pharmaceuticals investment in Series A - ReAlta Life Sciences
Children’s Research Holdings
Children’s Research Holdings investment in Series A - ReAlta Life Sciences
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - ReAlta Life Sciences
Official Site Inspections
http://www.realtalifesciences.com
- Host name: 174.177.227.35.bc.googleusercontent.com
- IP address: 35.227.177.174
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "ReAlta Life Sciences"
ReAlta Life Sciences, Inc.
ReAlta Life Sciences, a clinical stage company focused on rare diseases, has developed a novel class of drugs with unique dual-targeting therapeutic capabilities that rebalance complement …See details»
About Us - Realta Life Sciences
ReAlta Life Sciences is a clinical stage biotech company, dedicated to saving lives by rebalancing the inflammatory response through our EPICC technology platform. Our Science. Our Core Values. Our core values are deeply ingrained …See details»
ReAlta Life Sciences | LinkedIn
ReAlta Life Sciences is a clinical-stage biotech company dedicated to saving lives by rebalancing the inflammatory response to address life threatening acute inflammatory and rare diseases.See details»
ReAlta Life Sciences - Crunchbase Company Profile & Funding
ReAlta Life Sciences is a clinical-stage biotech company dedicated to harnessing the power of the immune system to address life-threatening rare diseases. The company’s EPICC peptides are …See details»
Investors - Realta Life Sciences
It was established as an 88-bed, not-for-profit hospital in 1961 by The King’s Daughters, a women’s service organization dedicated to the health and wellbeing of the community’s indigent children.See details»
Company Profile for ReAlta Life Sciences, Inc. | Business …
Jul 28, 2020 · ReAlta Life Sciences, Inc. is a clinical stage biotech company dedicated to harnessing the power of the immune system through its PIC1 technology plat.See details»
ReAlta Life Sciences Invigorates Executive Team with …
Aug 22, 2024 · David Marek, a current ReAlta Board member and accomplished executive who, as CEO of Myovant Sciences, led the organization through the landmark sale of the company, has been appointed Chief ...See details»
ReAlta Life Sciences - Overview, News & Similar companies
Feb 20, 2024 · View ReAlta Life Sciences (www.realtalifesciences.com) location in Virginia, United States , revenue, industry and description. Find related and similar companies as well …See details»
ReAlta Life Sciences Company Overview, Contact Details
Jun 8, 2021 · ReAlta Life Sciences (“ReAlta”), Inc., a clinical stage, rare disease company addressing life-threatening diseases through harnessing the power of the immune system, …See details»
ReAlta Life Sciences Announces Appointment of Distinguished ...
Nov 21, 2024 · NORFOLK, Va.-- (BUSINESS WIRE)-- ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by …See details»
ReAlta Life Sciences - VentureRadar
Website: https://realtalifesciences.com/ Develops novel dual-targeting drugs with a multi-modal technology platform (PIC1) that rebalances complement and inflammatory processes, …See details»
News & Industry Updates - Realta Life Sciences
Norfolk, VA, November 5, 2024 – ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to... Read More. Press Releases Sep 23, …See details»
ReAlta Life Sciences Strengthens Board of Directors with …
Jan 3, 2024 · ReAlta Life Sciences, Inc. is a mid-stage clinical biotech company dedicated to saving lives by rebalancing the inflammatory response to address life threatening acute …See details»
ReAlta Life Sciences Announces Dosing of First Patient in Phase 2 …
Feb 21, 2024 · For more information about the study, please visit https://www.clinicaltrials.gov (NCT06175065).See details»
Research & Development - Realta Life Sciences
Research & Development - Realta Life Sciences. ReAlta Focuses on Three Major Therapeutic Areas. ReAlta’s efforts are focused on developing therapies that leverage our unique dual …See details»
ReAlta Life Sciences Invigorates Executive Team with …
Aug 22, 2024 · ReAlta Life Sciences, Inc. is a clinical mid-stage biotech company dedicated to saving lives by rebalancing the inflammatory response to address life threatening acute …See details»
ReAlta Life Sciences Announces Proof of Mechanism Data from …
Jun 1, 2023 · ReAlta Life Sciences, Inc. is a mid-stage clinical biotech company dedicated to harnessing the power of the immune system to address life threatening rare diseases.See details»
News Release - Realta Life Sciences
Apr 21, 2020 · ReAlta Life Sciences, Inc. is a biotech company dedicated to harnessing the power of the immune system through its PIC1 technology platform, comprised of a family of over 160 …See details»
Trump team signs a key transition agreement with Biden White …
1 day ago · This is one of two agreements that was supposed to have been signed by Oct. 1. The Trump team has decided to forgo the second one, saying it has its own systems in place.See details»
ReAlta Life Sciences Closes $20 Million Series A3 ... - Business Wire
Apr 28, 2021 · ReAlta Life Sciences, Inc. is a clinical stage biotech company dedicated to harnessing the power of the immune system through its EPICC technology platform, …See details»